Search
for
Sort by
Research 211–240 of 1000+
- Development of PEGylated Liposomes
- Rare Cutaneous Side Effects of Imiquimod: A Review on Its Mechanisms, Diagnosis, and Management
- Roles of tumor suppressors in regulating tumor-associated inflammation
- Activity of Sorafenib against Desmoid Tumor/Deep Fibromatosis
- Tumour regression predicts higher risk of sentinel node involvement in thin cutaneous melanomas
- Malignant epithelial tumors: Part II. Therapy and prevention
- Tumor Necrosis Factor in Sepsis
- Spontaneous tumour regression in keratoacanthomas is driven by Wnt/retinoic acid signalling cross-talk
- PTCH1 Germline Mutations and the Basaloid Follicular Hamartoma Values in the Tumor Spectrum of Basal Cell Carcinoma Syndrome (NBCCS)
- Expression Patterns of Gli-1, Pleckstrin Homology-Like Domain, Family A, Member 1, Transforming Growth Factor-β1/β2, and p63 in Sebaceous and Follicular Tumors
- Hydroxychloroquine modulates the progression of experimentally induced benign prostatic hyperplasia in rats via targeting EGFR/ERK/STAT3 and AR/FOXO1/TRAIL pathways: computational and in vivo studies
- Challenges in diagnosing ovarian sertoli-leydig cell tumors: A Peruvian case series
- Antitumor Activities of the Typhonium flagelliforme Extract Combined with Natural Interferons of Canine and Feline in Mice with DMBA Induced Skin Tumors
- An ovarian Leydig cell tumor of ultrasound negative in a postmenopausal woman with hirsutism and hyperandrogenism
- Gender differences in tumor and patient characteristics in those undergoing Mohs surgery.
- Dermoscopy: distinguishing malignant tumors from benign
- Alisertib is active as single agent in recurrent atypical teratoid rhabdoid tumors in 4 children
- Target-Adverse Events and Fear of Cancer Progression, Anxiety, and Depression in Patients with Advanced Non-Small Cell Lung Cancer
- Hair shaft miRNA‐221 levels as a new tumor marker of malignant melanoma
- Original synthetic monophenolic antioxidant with combined effect inhibits tumor growth in vivo
- RE: EFFECT OF THE DUAL 5α-REDUCTASE INHIBITOR DUTASTERIDE ON MARKERS OF TUMOR REGRESSION IN PROSTATE CANCER
- Novel small molecules downregulate CDK1 expression and inhibit Wnt/β-catenin signaling in cutaneous squamous cell carcinoma by targeting its distinct tumor-specific cellular landscape
- Mathematical Modeling of Alopecia Areata: Unraveling Hair Cycle Dynamics, Disease Progression, and Treatment Strategies
- The genetic evolution of skin squamous cell carcinoma: tumor suppressor identity matters
- Abstract 5357: Targeting mTORC1 suppresses proliferation of keratinocyte stem cells and inhibits skin tumor promotion in mice
- Basement Membranes in Experimentally Induced Skin Tumors
- Dormant tumor cells in ret transgenic mouse melanoma model and their interaction with memory T cells
- Investigating the Role of Metabolism in Tissue Homeostasis and Tumor Initiation by Hair Follicle Stem Cells
- Stem cell quiescence acts as a tumour suppressor in squamous tumours
- Tracing the cellular origin of cancer